Medication info
Sitagliflozin, Dapagliflozin, Metformin Extended-Release Tablets 5/50/1000 mg

Sitagliflozin, Dapagliflozin, Metformin Extended-Release Tablets 5/50/1000 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›1000mg / 1 tabletSitagliptin Phosphate Hydrate›64.25mg / 1 tabletDapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Dongkook Pharmaceutical Co., Ltd.
Appearance
Orange oval extended-release film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202401788 · Approved 2024.07.24 · Insurance code 653405800

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
Take this medicine once daily in the evening with a meal. Take 1 tablet of the 10/100/1000 mg extended-release tablet once daily. Take 2 tablets of the 5/50/500 mg, 5/50/750 mg, and 5/50/1000 mg extended-release tablets once daily. The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, and the maximum daily dose is 1000 mg.

Ingredients

Manufacturer
Dongkook Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes

View approved original text

This medication is prescribed to assist in blood sugar control for patients with type 2 diabetes when used in conjunction with dapagliflozin, sitagliptin, and metformin. It helps to effectively manage blood sugar levels alongside dietary and exercise regimens. This contributes to maintaining stable blood sugar levels and reducing the risk of complications associated with diabetes. It supports safe and effective blood sugar control considering the patient's lifestyle and concomitant medications. This medication improves blood sugar control in type 2 diabetes patients.

How to take

Adult dose

Take this medicine once daily in the evening with a meal. Take 1 tablet of the 10/100/1000 mg extended-release tablet once daily. Take 2 tablets of the 5/50/500 mg, 5/50/750 mg, and 5/50/1000 mg extended-release tablets once daily. The starting dose of extended-release metformin hydrochloride is 500 mg or 750 mg once daily, and the maximum daily dose is 1000 mg.

Precautions

This medication contains three components: sitagliptin, dapagliflozin, and metformin, each of which is used for diabetes treatment. Sitagliptin may occasionally cause severe allergic reactions; if symptoms such as skin rash, difficulty breathing, or facial swelling occur within three months after administration, discontinue use immediately. Additionally, acute pancreatitis may occur, so if symptoms such as abdominal pain or vomiting arise, inform your doctor immediately. Dapagliflozin increases fluid excretion from the body and may cause blood pressure drop or dehydration; elderly patients or those with reduced kidney function should be carefully monitored. The risk of genital infections and urinary tract infections may increase during the use of this medication, so treatment should be sought immediately if infection symptoms appear. Rare infectious complications such as severe perineal necrosis (Fournier's gangrene) have also been reported, requiring immediate medical attention if symptoms arise. Metformin rarely causes a life-threatening metabolic disorder known as lactic acidosis; therefore, it should not be administered to patients with impaired kidney function or severe infections, dehydration, or liver dysfunction. Gastrointestinal disturbances (nausea, vomiting, diarrhea, etc.) may occur during use; caution is advised, and excessive alcohol consumption should be avoided. Regular kidney function checks are required while on this medication, and the medication should be discontinued if kidney function deteriorates. Additionally, discontinuation is recommended when surgery is planned or during severe infections or dehydration. Symptoms of hypoglycemia may occur, so particularly when used in combination with insulin or sulfonylureas, blood sugar levels should be monitored closely. It is important to consult healthcare providers immediately if any unusual symptoms or side effects are suspected while taking this medication.

Side effects

Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hemorrhagic pancreatitis, necrotizing pancreatitis, severe lactic acidosis, hypoglycemia, genital infections, vulvovaginitis, balanitis, fungal infections, perineal necrosis, decreased fluid volume, dehydration, hypovolemia, hypotension, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, elevated hematocrit, elevated serum creatinine, elevated blood urea, dyslipidemia, urinary tract infections, cystitis, Escherichia coli urinary tract infections, genitourinary infections, pyelonephritis, cystitis, urethritis, kidney infection, prostatitis, rash, generalized rash, pruritic rash, maculopapular rash, pustular rash, vesicular rash, erythematous rash, gastroesophageal reflux disease, upper abdominal pain, diverticulosis, intestinal perforation, chronic pancreatitis, hyperglycemia, sensory disturbances, cerebral infarction, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, weakness, pain, ligament sprain, road traffic accident, drug overdose, ankle fracture, hand fracture, pelvic fracture, meniscal injury, thoracic vertebrae fracture, tibia fracture, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric cancer, anaphylactic reaction, acute pyelonephritis, chest pain, dyspepsia, nausea, diarrhea, vomiting, urinary retention, elevated alanine aminotransferase, elevated aspartate aminotransferase, decreased appetite, headache, nasopharyngitis, upper respiratory tract infection, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus, taste disturbance, erythema, rash

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and the temperature should be maintained between 1 and 30 degrees Celsius at room temperature. Storing it this way helps maintain the medication's efficacy and safety.

Appearance and packaging

Appearance

Orange oval extended-release film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.